Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Vaccine. 2021 May 6;39(19):2719-2729. doi: 10.1016/j.vaccine.2021.03.002. Epub 2021 Apr 13.
Invasive meningococcal disease (IMD) caused by serogroup W meningococci belonging to the ST-11 complex (MenW:cc11) has been increasing globally since the early 2000s. Penicillin resistance among meningococci due to the production of beta-lactamase remains relatively rare. Isolates displaying resistance and reduced susceptibility to penicillin due to alterations in the penA gene (encoding Penicillin Binding Protein 2) are increasingly reported. In 2016, a penicillin-resistant clade of MenW:cc11 isolates with altered penA genes was identified in Australia. More recently, an increase in penicillin-resistant invasive MenW:cc11 isolates was observed in England. Here, we investigate the distribution of penicillin resistance among English invasive MenW:cc11 isolates.
Isolates from IMD cases in England from July 2010 to August 2019 underwent whole genome sequencing and antibiotic susceptibility testing as part of routine surveillance. The PubMLST Neisseria database was used to determine the distribution of penicillin resistance among English MenW:cc11 isolates and to identify other closely related isolates.
Twenty-five out of 897 English invasive MenW:cc11 isolates were resistant to penicillin; identified among six distinct sublineages and a singleton. Expansion of the Australian penicillin-resistant clade included isolates from several new countries as well as 20 English isolates. A newly identified penicillin resistance-associated lineage was also identified among several countries.
Penicillin resistance among diverse MenW:cc11 isolates is increasing. Surveillance of antibiotic resistance among meningococci is essential to ensure continued effective use.
自 21 世纪初以来,由属于 ST-11 复合物的血清群 W 脑膜炎奈瑟菌(MenW:cc11)引起的侵袭性脑膜炎奈瑟菌病(IMD)在全球范围内不断增加。由于产生β-内酰胺酶,脑膜炎奈瑟菌对青霉素的耐药性仍然相对罕见。由于 penA 基因(编码青霉素结合蛋白 2)的改变,导致对青霉素耐药和敏感性降低的分离株越来越多地被报道。2016 年,在澳大利亚鉴定出了具有改变的 penA 基因的耐青霉素 MenW:cc11 分离株的青霉素耐药克隆。最近,在英国观察到侵袭性耐青霉素的 MenW:cc11 分离株的数量增加。在这里,我们研究了英国侵袭性 MenW:cc11 分离株中青霉素耐药的分布情况。
作为常规监测的一部分,对 2010 年 7 月至 2019 年 8 月期间在英国发生的 IMD 病例的分离物进行全基因组测序和抗生素药敏试验。使用 PubMLST Neisseria 数据库确定英国 MenW:cc11 分离株中青霉素耐药的分布情况,并鉴定其他密切相关的分离株。
897 株英国侵袭性 MenW:cc11 分离株中有 25 株对青霉素耐药;鉴定出 6 个不同的亚谱系和一个单体。澳大利亚耐青霉素克隆的扩张包括来自几个新国家的分离株以及 20 株英国分离株。还在几个国家鉴定出了一个新的与青霉素耐药相关的谱系。
不同 MenW:cc11 分离株的青霉素耐药性正在增加。对抗生素耐药性监测是确保持续有效使用的关键。